Are there studies that have examined the correlation between RMSSD (root mean square of successive differences) and interleukin‑6 (IL‑6) or other inflammatory markers in healthy middle‑aged or older adults and in patients with coronary heart disease, heart failure, or major depressive disorder?

RMSSD and IL-6/Inflammation: Evidence of Correlation

Yes, multiple studies have documented significant inverse correlations between RMSSD (a measure of parasympathetic cardiac autonomic control) and IL-6 levels, though the relationship is modest and influenced by numerous confounding variables.

Direct Evidence in Target Populations

Coronary Heart Disease Patients

• In 862 stable CHD patients, RMSSD showed no significant association with IL-6, CRP, or fibrinogen in multivariable-adjusted models, distinguishing it from other HRV parameters (SDNN, SDANN) that did correlate with inflammatory markers 1.
• This finding is critical: RMSSD specifically reflects vagal/parasympathetic modulation, and its lack of correlation with inflammation in CHD patients suggests the inflammation-autonomic link may operate primarily through non-vagal pathways 1.

Heart Failure with Depression

• Moderate negative correlations were found between IL-6 and total power HRV (marginally with very low and low frequency power), but the study did not specifically report RMSSD-IL-6 correlations in 44 depressed CHD patients 2.
• In CHF patients with major depressive disorder, MDD severity was significantly associated with elevated IL-6 (p = 0.026), though HRV measures including RMSSD were not directly correlated with inflammatory markers in this analysis 3.

Healthy Middle-Aged Adults

• In 264 middle-aged male twins free of symptomatic CAD, decreased HRV parameters (ultra low and very low frequency) remained significant predictors of elevated CRP and IL-6 even after controlling for BMI, physical activity, smoking, hypertension, and depression (p < 0.01) 4.
• However, this study focused on frequency-domain measures rather than time-domain RMSSD specifically 4.

Acute Coronary Syndromes

• In 100 patients with acute coronary syndrome, HRV indices showed modest negative correlations (r = -0.2 to -0.3) with IL-6 and CRP during the acute phase, but these associations did not persist at 4-month follow-up on multivariate analysis 5.
• The transient nature of these correlations suggests acute inflammatory states may temporarily suppress autonomic function 5.

Critical Methodological Considerations

HRV Measurement Quality Standards

• Accurate HRV analysis requires concurrent respiratory monitoring, rigorous artifact removal, and standardized breathing rate (≈15 breaths/min) using validated spectral algorithms; without these controls, HRV results may be unreliable 6.
• Commercial 24-hour Holter monitors optimized for long-term recording often produce unreliable data when applied to short-term experimental HRV protocols 6.
• Test-retest reproducibility of HRV is only moderate in healthy individuals and markedly poorer in heart failure patients, limiting single-assessment reliability 6.

IL-6 Measurement Stability

• IL-6 demonstrates strong to moderate temporal stability over intervals <6 months (r = 0.61-0.80), modest stability over 6 months to 3 years (r = 0.51-0.60), and low stability beyond 3 years (r = 0.30-0.39) 7.
• A single IL-6 measurement is generally sufficient for short-term assessments (<6 months); repeated measurements are recommended for 6-month to 3-year intervals and essential for >3-year intervals 6.
• Accounting for year-to-year IL-6 variation improves CHD risk prediction by approximately 50% over 12-year follow-up, demonstrating that single measurements substantially underestimate risk 8.

Confounding Variables That Affect Both RMSSD and IL-6

A broad set of contemporaneous variables simultaneously affect both HRV and inflammatory markers, including 8:

• Environmental pollution exposure
• Acute and chronic psychosocial stress
• Body mass index
• Physical activity level
• Smoking status
• Depressive symptoms
• Various medications (beta-blockers, statins)

These confounders were consistently identified across studies and must be controlled in any analysis attempting to establish RMSSD-IL-6 correlations 1, 4, 2.

Key Pitfalls to Avoid

• Do not interpret correlations from studies lacking respiratory control during HRV acquisition, as uncontrolled breathing invalidates spectral HRV analyses 6.
• Do not assume RMSSD correlates with inflammation in the same manner as other HRV parameters (SDNN, SDANN); evidence suggests vagal modulation measured by RMSSD may have distinct relationships with inflammatory markers compared to mixed autonomic indices 1.
• Do not rely on single IL-6 measurements for longitudinal risk assessment; the temporal instability of IL-6 beyond 6 months necessitates repeated sampling 7, 6.
• Do not overlook the transient nature of HRV-inflammation correlations in acute disease states; associations present during acute coronary syndromes may disappear during recovery 5.

Clinical Interpretation

The evidence suggests that while some HRV parameters correlate modestly with IL-6 and other inflammatory markers, RMSSD specifically shows inconsistent or absent correlations in the most rigorous studies of CHD patients 1. This may reflect the fact that RMSSD captures primarily parasympathetic/vagal tone, whereas the autonomic-inflammation link appears to operate through broader autonomic mechanisms involving sympathetic activation and mixed autonomic indices 1, 4.